"Leading Mobile Healthcare Company" FANGZHOU JIANKE (06086) to Form Strategic Partnership with Tencent to jointly promote the upgrade of internet healthcare intelligence.

On September 19th, FANGZHOU JIANKE (06086), known as the "first stock in mobile healthcare," held the 9th H2H Medical Service Ecological Conference in Shanghai. The conference, themed "Smart Healthcare Innovation-Driven," gathered experts from the pharmaceutical industry, well-known domestic and international pharmaceutical companies, frontline workers, and other guests to share their experiences on topics such as the multi-billion market of internet hospitals, efficient operational models for internet doctors, and innovative digital marketing from different perspectives, providing innovative development ideas and inspiration for the industry. Of particular note, at the conference, Dr. Xie Fangmin, the founder, chairman, and CEO of FANGZHOU JIANKE, along with Yan Peng, Vice President of Tencent Cloud and Vice President of Tencent Health, signed a strategic cooperation agreement. The two parties will deepen cooperation in the fields of internet healthcare, chronic disease management services, digital innovation, and more, to jointly elevate the overall level of the industry and provide users with more efficient and intelligent healthcare services. FANGZHOU JIANKE, the largest online chronic disease management service platform in China, with its outstanding H2H intelligent healthcare ecosystem, is leading an industry transformation from hospitals to homes and from offline to online health services through technological empowerment. Tencent, as a digital technology giant in China and globally, is actively expanding its presence in the medical field, serving medical, medical insurance, and pharmaceutical enterprises to enhance the efficiency of the entire medical system. Based on the industry, serving the public, FANGZHOU JIANKE and Tencent have a deep consensus on digital strategy, technological innovation, user experience, and ecological cooperation, aligning with the concept of serving public health. In 2023, FANGZHOU JIANKE and Tencent Cloud will cooperate in various areas such as cloud infrastructure, user private domain operations, medical education content, and AIGC (Generative Adversarial Networks). In 2024, the strategic cooperation between the two parties will deepen further. FANGZHOU JIANKE and Tencent will leverage their respective strengths to expand the influence of professional medical education and user outreach through "Tencent Medical Dictionary." Additionally, they will continue to integrate with "Tencent Health Pharmacy Box," relying on WeChat, a national-level social platform, to provide more accurate and personalized medication reminders, disease tracking, and other services to every user and patient, showcasing a combination of technological warmth and human care. The renewed cooperation between FANGZHOU JIANKE and Tencent not only sparks innovation but also represents a profound exploration and reshaping of the internet healthcare management model. "In the past two years, the industry has entered a restructuring phase, which means that leading companies are focusing on building their own capabilities, especially in the construction of core internet hospitals and chronic disease management service centers," said Dr. Xie Fangmin, the founder, chairman, and CEO of FANGZHOU JIANKE in his keynote speech on "Deepening Smart Healthcare, Innovation Leading the Future." FANGZHOU JIANKE has always adhered to a development strategy centered on technological innovation and customer-centricity, gaining market recognition through high-quality patient services and professional medical services. As the "first stock in mobile healthcare," FANGZHOU JIANKE successfully listed on the main board of the Hong Kong Stock Exchange in July. Data shows that FANGZHOU JIANKE has attracted 45.6 million registered users, 217,000 registered doctors, conducted over 8,000 science popularization and education live broadcasts, participated in national natural scientific research foundation projects, and obtained 23 artificial intelligence patents... Seizing the opportunities of digitalization, in 2024, FANGZHOU JIANKE presented a "report card" that boosted industry confidence. Moreover, FANGZHOU JIANKE has comprehensively upgraded its business in areas such as internet hospitals, artificial intelligence algorithms, supply chain links, and health education matrices, advancing towards the digitized journey of Internet healthcare 2.0. It is understood that, relying on internet hospitals and dual-channel pharmacies, FANGZHOU JIANKE has fully connected Guangzhou's medical insurance online settlement channels and will continue to launch more main products to alleviate the burden on patients. At the same time, FANGZHOU JIANKE is dedicated to creating an excellent domestic medical service center, linking Internet hospitals with medical services closely. By optimizing the medical supply chain comprehensively, more innovative drugs are brought to patients, bringing "New Hope Liuhe." The strong alliance between FANGZHOU JIANKE and Tencent will help realize the beautiful vision of empowering the medical industry with technology, providing a better product and service experience for the people, and promoting the healthy future of China's internet medical industry, injecting new vitality into the future development of the medical industry while adhering to the original intention.